Regorafenib for the Treatment of Sarcoma

Marie‐Cécile Le Deley, Jean Yves Blay, Jennifer Wallet, François Bertucci, Emmanuelle Bompas, Thomas Brodowicz, L. Chaigneau, Christine Chevreau, Emilie Decoupigny, Antoîne Italiano, Bernadette Lieg-Atzwanger, Olivier Mir, Sophie Piperno‐Neumann, Julien Thery, Axel Le Cesne, Nicolas Penel

Article2020

Cabozantinib as an emerging treatment for sarcoma

Patrick Schöffski, Jean Yves Blay, Isabelle Ray‐Coquard

Article2023

Radiotherapy in bone sarcoma: the quest for better treatment option

Marie-Anaïs Locquet, Mehdi Brahmi, Jean Yves Blay, Aurélie Dutour

Article2021

Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression

Atsushi Hiraoka, Takashi Kumada, Takeshi Hatanaka, Toshifumi Tada, Kazuya Kariyama, Joji Tani, Shinya Fukunishi, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kazuhito Kawata, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Tsutomu Tamai, Satoru Kakizaki, ,

Hiroki Tojima

Tamon Nagashima,

Takashi Ueno,

Daichi Takizawa,

Atsushi Naganuma,

Hideko Ohama,

Kazuhiro Nouso,

Akemi Tsutsui,

Takuya Nagano,

Norio Itokawa,

Tomomi Okubo,

Taeang Arai,

Michitaka Imai,

Yohei Koizumi,

Shinichiro Nakamura,

Kouji Joko,

Kojiro Michitaka,

Yoichi Hiasa,

Masatoshi Kudo